Product Information

CEFPROZIL 125 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1076 per ML under NDC 68180040103. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 19, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFPROZIL 125 MG/5 ML SUSP

CEFPROZIL
$0.1076per ML

Strength

125 mg/5mL

NDC

68180040103

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CEFPROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065261

FDA Approved

12/19/2005

TE Code

AB

On Market Since

12/1/2005

Price Statistics

The NADAC for CEFPROZIL 125 MG/5 ML SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 65.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1076 per ML
All-time high$0.3098 (Dec 11, 2013)
All-time low$0.0917 (Jan 18, 2023)
52-week high$0.1195
52-week low$0.0986
Median price$0.1775
Average price$0.1968
Largest weekly change+73.0% (May 18, 2022)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+2.6%

3M

+1.4%

6M

-6.6%

1Y

-13.5%

3Y

-30.9%

5Y

-58.3%

All

-65.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CEFPROZIL market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CEFPROZIL 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 125 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.1076 per ML (NDC 68180040103), effective Nov 11, 2026.

How has the price of CEFPROZIL 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has declined 65.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEFPROZIL 125 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has ranged from a low of $0.0917 (Jan 18, 2023) to a high of $0.3098 (Dec 11, 2013), with a median of $0.1775 per ML.

Are there cheaper alternatives to CEFPROZIL 125 MG/5 ML SUSP?

No other NADAC-published product currently shares the active ingredient and strength of CEFPROZIL 125 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CEFPROZIL 125 MG/5 ML SUSP?

CEFPROZIL 125 MG/5 ML SUSP (NDC 68180040103) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.